Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
TXG Stock — 10x Genomics Inc.
10x Genomics Inc. (TXG)
Updated October 16, 2026.
TXG is a Stock. Total return is 32.4% over the past 7.1 years, 148.9 points behind SPY at 181.3%.
10x Genomics develops and sells instruments, consumables, and software for single-cell and spatial analysis of biological systems, serving academic, government, and biopharmaceutical institutions globally. The company does not currently distribute dividends. This stock may appeal to growth-oriented investors seeking exposure to life sciences research tools and genomics technology.
TXG performance versus SPY
Price and return data through 2026-10-16.
Total return is 32.4% over the past 7.1 years, 148.9 points behind SPY at 181.3%. Over the past year its total return — price change plus distributions reinvested — is 464.3%. Its deepest 1-year drawdown was 28.5%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -3.9% | — |
| 3M | 57.1% | — |
| 6M | 176.8% | — |
| YTD | 328.3% | — |
| 1Y | 464.3% | — |
| 2Y CAGR | — | 110.80% |
| 3Y CAGR | — | 21.50% |
| 5Y CAGR | — | -14.40% |
| Since inception (7.1 years) | 32.4% | 4.00% |
TXG key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 09/12/2019
- Distribution frequency
- None
- Last close
- $69.86 (as of 2026-10-16)
- Market cap
- $8,398,030,999
- Average volume
- 3385456.0
- Beta
- 1.991
- Payout ratio
- 0.0%
- Forward P/E
- 1250.0
- EPS
- $-0.59
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
TXG risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 28.5%.
Who may consider TXG — and who may not
It is a weaker fit for investors who need monthly cash flow (TXG does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on TXG
Frequently asked questions
Does TXG pay monthly?
No. TXG does not currently distribute.
When does TXG pay a dividend?
TXG does not currently distribute.
How has TXG performed?
Total return is 32.4% over the past 7.1 years, 148.9 points behind SPY at 181.3%. Over the past year its total return — price change plus distributions reinvested — is 464.3%. Its deepest 1-year drawdown was 28.5%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.